Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.34 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.34 |
| ▸ | CYP17A1 | P05093 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | JAK2 | O60674 | 1/20 | 0.34 |
| ▸ | DHODH | Q02127 | 3/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | TDO2 | P48775 | 1/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.33 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.32 |
| ▸ | CDK2 | P24941 | 1/20 | 0.32 |
| ▸ | SLC34A1 | Q06495 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21187487 | 0.93 | TDO2 (0.35) | NISCHALDH1A1CACNA1BAPBA1CYP17A1 | |
| SCHEMBL21187440 | 0.85 | SLC34A1 (0.35) | CYP17A1JAK2HSD11B1SLC34A1 | |
| SCHEMBL22599079 | 0.83 | ATM (0.36) | ALDH1A1CYP1A2JAK2DHODHMAPK14 | |
| SCHEMBL21187443 | 0.81 | TDO2 (0.35) | NISCHALDH1A1CYP17A1JAK2TDO2 | |
| SCHEMBL21187441 | 0.79 | RAPGEF4 (0.35) | HSD11B1TDO2MAPK14 | |
| SCHEMBL22599011 | 0.79 | S1PR4 (0.36) | ALDH1A1CYP1A2DHODHHSD11B1MAPK14 | |
| SCHEMBL21187575 | 0.79 | EGFR (0.36) | HSD11B1TDO2SLC34A1 | |
| SCHEMBL21187483 | 0.77 | RAPGEF4 (0.39) | DHODH | |
| SCHEMBL21187438 | 0.75 | HSD11B1 (0.42) | NISCHCYP17A1CYP1A2HSD11B1MAPK14 | |
| SCHEMBL21187476 | 0.73 | HSD11B1 (0.43) | NISCHCYP17A1CYP1A2HSD11B1MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3740474-B1 | AGRICULTURAL CHEMICALS | GLOBACHEM NV (BE) | 2022-01-05 | — | — | EP | disclosed |
| US-20200339543-A1 | AGRICULTURAL CHEMICALS | GLOBACHEM NV (BE) | 2020-10-29 | — | — | US | disclosed |
| WO-2019141972-A1 | AGRICULTURAL CHEMICALS | GLOBACHEM NV (BE) | 2019-07-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200339543-A1 | AGRICULTURAL CHEMICALS | ABAT, BRDT, GABBR1 | NISCH 98/4885ALDH1A1 506/4885CACNA1B 1229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.